Concepedia

Naoya Ikeda

NI

Statistics

Publications

54

Citations

3.5K

H-Index

30

Active since

1989

Affiliations

Nara Medical University(Current)

University of Tsukuba

Kansai Medical University

Kitano Hospital

Yokohama City University

Naoya Ikeda is an author at Nara Medical University specializing in medicine, oncology, and pancreatic cancer.

ORCID

Publications per year

1989–2024

54

Publications

54

Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer

Yuichiro Ohigashi, Masayuki Sho, Yukishige Yamada et al. · Clinical Cancer Research · 2005 · 792 citations · Full text

, , +17

Prognostic significance of angiogenesis in human pancreatic cancer

Naoya Ikeda, Masashi Adachi, Toshihiko Taki et al. · British Journal of Cancer · 1999 · 317 citations · Full text

, , +13

Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer.

Takamune Shibaji, Mitsuo Nagao, Naoya Ikeda et al. · PubMed · 2004 · 141 citations

, , +17

RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators

Andrew Redfern, Shane M. Colley, Dianne J. Beveridge et al. · Proceedings of the National Academy of Sciences · 2013 · 128 citations · Full text

, , +17

Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.

Naoya Ikeda, Yoshiyuki Nakajima, Takahiro Tokuhara et al. · PubMed · 2003 · 126 citations

, , +17

1–5 of 54